Feasibility and morbidity of combined hyperthermia and radiochemotherapy in recurrent rectal cancer - Preliminary results

Onkologie

Volumn 26, Issue 2, 2003, Pages 120-124

  Schaffer, M ^a   Krych, M ^a   Pachmann, Sophia ^a   Abdel Rahman, S ^a   Schaffer, P M ^a   Ertl Wagner, B ^b   Duhmke E ^a   Issels, R D ^a,c  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Chemotherapy; Colorectal cancer; Hyperthermia; Irradiation; Recurrence

Indexed keywords

ANALGESIC AGENT; FLUOROURACIL; OPIATE;

ABSCESS; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERTHERMIC THERAPY; ILEUS; MALE; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; RADIATION DOSE; RECTUM CANCER; SIDE EFFECT; SKIN MANIFESTATION; TREATMENT OUTCOME; WOUND HEALING IMPAIRMENT;

ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, INTRAVENOUS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0038654050     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069830     Document Type: Article

References (19)

1. Hu KS, Harrison LB: Adjuvant therapy for resectable rectal adenocarcinoma. Semin Surg Oncol 2000;19:336-349.
2. Ngan SY: Optimising treatment for resectable rectal cancer: Is preoperative therapy beneficial? Drugs Aging 2001;18:79-85.
3. Janian NA, Crane C, Feig BW, Cleary K, Dubrow R, Curely S, Vauthey JN, Lynch P, Ellis LM, Wolf R, Lenzi R, Abruzzese J, Pazdur R, Hoff PM, Allen P, Brown T, Skibber J: Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol 2001;24:107-112.
4. Rau B, Wust P, Tilly W, Gellerman J, Harder C, Riess H, Budach V, Felix R, Schlag PM: Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: Regional radiofrequency hyperthermia correlates with clinical parameters. Int J Radiat Oncol Biol Phys 2000;48:381-391.
5. Anscher MS, Lee C, Hurwitz H, Tyler D, Prosnitz LR, Jowell P, Rosner G, Samulski T, Dewhirst MW: A pilot study of hyperthermia continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancer. Int J Radiat Oncol Biol Phys 2000;47:719-724.
6. van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA: Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumors: A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000; 355:1119-1125.
7. Falk MH, Issels RD: Hyperthermia in oncology. Int J Hyperthermia 2001;1:1-18.
8. Xia T, Sun Q, Shi X, Fan N, Hiraoka M: Relationship between thermal parameters and tumor response in hyperthermia combined with radiation therapy. Int J Clin Oncol 2001;6:138-142.
9. Seegenschmiedt MH: Interdisciplinary documentation of treatment side effects in oncology. Present status and perspectives. Strahlenther Oncol 1998;174(suppl 3):25-29.
10. Trotti A: The evaluation and application of toxicity criteria. Semin Radiat Oncol 2002;12(suppl 1):1-3.
11. Maetani S, Onodera H, Nishikawa T, Morimoto H, Ida K, Kitamura O, Imamura M: Significance of local recurrence of rectal cancer as a local or disseminated disease. Br J Surg 1998;85:521-525.
12. Perera F, Fisher B, Kocha W, Plewes E, Taylor M, Vincent M: A phase I pilot study of pelvic radiation and alpha-2A interferon in patients with locally advanced or recurrent rectal cancer. Int J Radiat Oncol Biol Phys 1977;37:297-303.
13. Rutten HJ, Mannaerts GH, Martijn H, Wiggers T: Intraoperative radiotherapy for locally recurrent rectal cancer in the Netherlands. Eur J Surg Oncol 2000;26(suppl A):S16-S20.
14. Lingareddy V, Ahmad NR, Mohiuddin M: Palliative reirradiation for recurrent rectal cancer. Int J Radiat Oncol Biol Phys 1997;38:785-790.
15. Hartung G, Hofheinz RD, Wein A, Riedel C, Rost A, Fritze D, Kreuser ED, Drees M, Kühnel J, Hehlmann R, Queißer W: Phase II study of a weekly 24 hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first line treatment of metastatic colorectal cancer. Onkologie 2001;24:457-462.
16. Calvo FA, Gomez Espi M, Diaz-Gonzales JA, Cantalapiedra R, Marcos P, Alvarado A, Garcia Alfonso P, Herranz R, Alvarez E: Pathologic down-staging of T3-4Nx rectal cancer after chemoradiation; 5-fluorouracil vs. Tegafur. Int J Radiat Oncol Biol Phys 2001;51:1264-1270.
17. Rödel C, Sauer R: Perioperative radiotherapy and concurrent radiochemotherapy in rectal cancer. Semin Surg Oncol 2001;20:3-12.
18. th Annual Meeting of the European Society for Hyperthermic Oncology, Verona, Italy, May 30-June 2, 2001, p 78, abstract.
19. Wust P, Gellermann J, Harder C, Tilly W, Rau B, Dinges S, Schlag P, Budach V, Felix R: Rationale for using invasive thermometry for regional hyperthermia of pelvic tumors. Int J Radiat Oncol Biol Phys 1998;41:1129-1137.